» Articles » PMID: 12626908

Prognostic Significance of Lateral Lymph Node Micrometastases in Lower Rectal Cancer: an Immunohistochemical Study with CAM5.2

Overview
Specialty Gastroenterology
Date 2003 Mar 11
PMID 12626908
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The aims of this study were to determine the rate of lymph node micrometastases and to evaluate their prognostic value in lateral lymph nodes in lower rectal cancer at or below the peritoneal reflection.

Methods: A retrospective analysis was made of 892 lymph nodes from 66 consecutive patients who had undergone radical resection with lateral lymph node dissection. These lymph nodes were examined immunohistochemically with an antibody against cytokeratins 7 and 8, CAM5.2.

Results: Routine hematoxylin-eosin staining revealed 9 patients with positive lateral lymph nodes that were stained consistently with CAM5.2. Among 57 patients in whom lateral lymph node metastases were not detected by hematoxylin-eosin staining, cytokeratin staining was positive in 19 nodes (2.7 percent) from 11 patients (19.3 percent). These 11 patients with micrometastases in lateral nodes showed a significantly high recurrence rate (P = 0.048) and worse overall survival (P = 0.01) than the 46 patients without lateral node metastases. The recurrence rate and overall survival of patients with micrometastases did not differ significantly from those of patients with positive lateral nodes with hematoxylin-eosin staining. Local recurrence developed in 6 of 66 patients, but neither the presence nor the absence of micrometastases in lateral nodes influenced the local recurrence rate.

Conclusion: The presence of nodal micrometastases leads to a poor prognosis. The survival of patients with micrometastases was not different from that of patients with overt metastases. Therefore, patients with cytokeratin-positive cells in lateral lymph nodes should be regarded as having overt metastases.

Citing Articles

MRI-based scoring systems for selective lateral lymph node dissection in locally advanced low rectal cancer after neoadjuvant chemoradiotherapy.

Cho M, Han K, Shin H, Koom W, Lee K, Kim J Eur Radiol. 2025; .

PMID: 39939420 DOI: 10.1007/s00330-025-11439-x.


Comparison of robotic and laparoscopic approaches in short- and long-term outcomes of lateral pelvic lymph node dissection for advanced rectal cancer: a Japanese multicenter study.

Ishii M, Tominaga T, Nonaka T, Takamura Y, Oishi K, Hashimoto S Langenbecks Arch Surg. 2024; 410(1):18.

PMID: 39729145 DOI: 10.1007/s00423-024-03596-2.


Role of Lateral Pelvic Node Dissection in Rectal Cancer Surgery.

Ozgur I, Gorgun E Clin Colon Rectal Surg. 2024; 37(4):222-228.

PMID: 38882936 PMC: 11178386. DOI: 10.1055/s-0043-1770711.


Robotic Lateral Pelvic Lymph Node Dissection in Rectal Cancer: A Feasibility Study from a European Centre.

Chang T, Ali O, Tsimogiannis K, Sica G, Khan J J Clin Med. 2024; 13(1).

PMID: 38202097 PMC: 10779823. DOI: 10.3390/jcm13010090.


Tumor Size >5 cm and Harvested LNs <12 Are the Risk Factors for Recurrence in Stage I Colon and Rectal Cancer after Radical Resection.

Jung H, Ryoo S, Lim H, Kim M, Moon S, Park J Cancers (Basel). 2021; 13(21).

PMID: 34771458 PMC: 8582375. DOI: 10.3390/cancers13215294.